Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ12401241-0,16
KB10451046-0,19
PKN78,478,42-8,03
Msft530,42530,620,24
Nokia3,5613,5650,06
IBM237,24237,51,12
Mercedes-Benz Group AG52,552,520,52
PFE24,8724,880,93
13.08.2025 15:46:53
Indexy online
AD Index online
select
AD Index online
 

  • 13.08.2025 15:41:36
Lear (LEA, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
100,38 0,42 0,42 9 053
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 13.08.2025
Popis společnosti

Business Summary: Lear Corporation is a global automotive technology company. The Company's segments include Seating and E-Systems. The Company's Seating segment consists of the design, development, engineering and manufacture of complete seat systems and key seat components. Its key seat component product offerings include seat trim covers; surface materials such as leather and fabric; seat mechanisms; seat foam; headrests; and thermal comfort systems such as seat heating, ventilation, active cooling, pneumatic lumbar and massage products. Its E-Systems segment consists of the design, development, engineering and manufacture of complete electrical distribution and connection systems; high-voltage power distribution products, including battery disconnect units (BDUs); and low-voltage power distribution products and electronic controllers. These capabilities enable it to provide its customers with customizable solutions with optimized designs for both low-voltage and high-voltage vehicle architectures.
Financial Summary: BRIEF: For the six months ended 28 June 2025, Lear Corp revenues decreased 3% to $11.59B. Net income decreased 13% to $245.9M. Revenues reflect Seating segment decrease of 3% to $8.63B, E-Systems segment decrease of 4% to $2.97B, North America segment decrease of 5% to $4.77B, Europe and Africa segment decrease of 5% to $4.23B. Net income also reflects Restructuring cost in COGS increase of 38% to $104.3M (expense).



  • Poslední aktualizace: 13.08.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Chief Financial Officer, DirectorJames Frakes6603.10.2024
Chief Medical OfficerSteven Larosa5704.01.2021